BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23831873)

  • 1. Hospitalisation associated with use of the synthetic cannabinoid K2.
    Glue P; Al-Shaqsi S; Hancock D; Gale C; Strong B; Schep L
    N Z Med J; 2013 Jun; 126(1377):18-23. PubMed ID: 23831873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicidal ideation and self-harm following K2 use.
    Thomas S; Bliss S; Malik M
    J Okla State Med Assoc; 2012 Nov; 105(11):430-3. PubMed ID: 23304900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic stroke following use of the synthetic marijuana "spice".
    Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS
    Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment: Spice, reversible cerebral vasoconstriction, and intracranial hemorrhage.
    Barber PA
    Neurology; 2015 Sep; 85(13):1179. PubMed ID: 26320205
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
    Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
    Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatric hospitalisation across the life span].
    Lay B; Rössler W
    Neuropsychiatr; 2011; 25(2):67-74. PubMed ID: 21672505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
    Mörkl S; Blesl C; Wurm WE; Tmava A
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute psychiatric admissions from an out-of-hours Casualty Clinic; how do referring doctors and admitting specialists agree?
    Deraas TS; Hansen V; Giaever A; Olstad R
    BMC Health Serv Res; 2006 Mar; 6():41. PubMed ID: 16571113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting.
    Joseph AM; Manseau MW; Lalane M; Rajparia A; Lewis CF
    Am J Drug Alcohol Abuse; 2017 Jan; 43(1):117-122. PubMed ID: 27797288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.